姚记科技(002605) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was CNY 534,420,305.80, representing a 37.00% increase compared to CNY 372,032,242.43 in the same period last year[9]. - Net profit attributable to shareholders was CNY 663,428,466.20, a significant increase of 1,080.36% from CNY 52,646,991.57 in the previous year[9]. - The net profit after deducting non-recurring gains and losses was CNY 144,493,827.59, up 181.75% from CNY 51,284,310.80 year-on-year[9]. - Basic earnings per share reached CNY 1.6626, a remarkable increase of 1,074.98% compared to CNY 0.1326 in the same quarter last year[9]. - The weighted average return on equity was 36.34%, up from 2.88% in the previous year, indicating a significant improvement in profitability[9]. - The company's operating revenue for the reporting period reached ¥534,420,305.80, representing a 37.00% increase compared to ¥390,098,310.31 in the same period last year[28]. - The net profit attributable to the parent company was ¥1,601,656,607.31, an increase of 70.71% from ¥938,228,141.11 year-on-year[28]. - The company reported a significant increase in other income, which rose by 613.98% to ¥11,389,979.00, primarily due to increased government subsidies received[28]. - The company’s investment income surged by 15194.52% to ¥502,811,745.93, resulting from the aforementioned accounting treatment change[28]. - The company's total comprehensive income attributable to the parent company was ¥663,428,404.30, compared to ¥56,205,838.83 in the previous period[70]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,539,865,028.78, reflecting a 17.18% increase from CNY 3,020,971,880.60 at the end of the previous year[9]. - Net assets attributable to shareholders increased by 34.44% to CNY 2,007,238,523.90 from CNY 1,493,007,959.33 year-on-year[9]. - The company's total current assets reached CNY 1,043,212,347.97, up from CNY 873,447,794.73, indicating a growth of about 19.4%[42]. - The total liabilities decreased slightly to CNY 1,443,744,332.40 from CNY 1,449,786,736.54, showing a reduction of about 0.4%[48]. - The company's equity attributable to shareholders rose to CNY 2,007,238,523.90 from CNY 1,493,007,959.33, marking an increase of approximately 34.4%[51]. - The total assets increased to CNY 3,471,391,350.07 from CNY 3,097,032,332.25, marking a growth of about 12%[59]. - The total liabilities amounted to CNY 1,396,017,286.14, slightly up from CNY 1,374,448,223.42, indicating a growth of about 2%[59]. - The owner's equity increased to CNY 2,075,374,063.93 from CNY 1,722,584,108.83, representing a growth of approximately 20%[59]. Cash Flow - The net cash flow from operating activities was CNY 136,801,283.27, a decrease of 14.57% compared to CNY 145,564,036.34 in the same period last year[9]. - The cash flow from investing activities showed a net outflow of ¥356,594,535.04, a decrease of 4445.67% compared to the previous year, mainly due to payments for acquisitions[28]. - The company secured a merger loan of ¥330,000,000 from Shanghai Pudong Development Bank, contributing to a 620.88% increase in cash flow from financing activities, totaling ¥353,592,806.63[28]. - Cash flow from operating activities amounted to ¥611,099,275.25, an increase from ¥456,570,829.52 in the previous period[78]. - The net cash flow from financing activities was 353,592,806.63, compared to a negative cash flow of -67,883,595.89 in the previous period, indicating a significant improvement[84]. - The cash outflow for operating activities was 186,999,669.10, significantly higher than 103,857,499.56 in the previous period, reflecting increased operational costs[85]. - The cash flow from investment activities included 11,500,000.00 received from other investment-related activities, down from 44,101,583.81 in the previous period, indicating reduced returns from investments[88]. Investments and Expenses - The company's long-term equity investment decreased by 94.71% to ¥15,529,288.95 due to a change in accounting treatment, transferring 14.21% equity in Shanghai Cell Therapy Group from long-term equity investment to other non-current financial assets[25]. - The total amount of other non-current financial assets increased by 2096.25% to ¥658,874,698.50, attributed to the same accounting treatment change[25]. - Research and development expenses for the quarter were CNY 28,579,664.76, compared to CNY 25,116,240.38 in the previous period, showing an increase of about 10%[63]. - The company's prepaid expenses increased by 401.49% to ¥33,780,068.22, primarily due to increased promotional expenses by its subsidiary[25]. - The company incurred financial expenses of ¥6,010,663.15, which is an increase from ¥3,224,589.45 in the previous period[71]. - Research and development expenses decreased to ¥94,412.92 from ¥136,803.19 in the previous period, reflecting a focus on cost management[71]. Shareholder Information - The top ten shareholders collectively hold 53.85% of the company's total shares, indicating a concentrated ownership structure[14].